National Library of Medicine – published January 2022 Gabriel Salerni , Emilia Cohen-Sabban , Horacio Cabo Introduction: Whether extrafacial lentigo maligna (EFLM) differs clinically and/or dermoscopically according to location has not been analyzed…
With the number of models available, this can seem to be a difficult decision. Whilst the amount of choice appears confusing, an understanding of some basic principles can assist. There…
The Medical Journal of Australia – published 9 May 2022 Professor David Whiteman and Professor Anne Cust MELANOMA is a common cancer in Australia. Each year in this country, more…
Stethoscope, otoscope, ophthalmoscope. Essential diagnostic tools that no primary health care practitioner can manage without. In this decade, another should be added to the list – the dermoscope. A Brief…
The best care for your patient… This is the best practice! Our teams focus on delivering safe, high quality and efficient tools which help medical practices implement strategies for the…
Current methods for diagnosing skin cancers rely on either invasive biopsies or the use of a dermatoscope and additional digital skin imaging software which can monitor the skin over time….
MoleMax Systems, a division of Macquarie Medical Systems, specialises in the development and production of dermatoscopic hardware and software, including dermatoscopes and the MoleMax Dermoscopy Software. These integrated solutions are designed for early clinical imaging sessions, analysis and comparisons of skin cancer, providing dermatologists with advanced tools for high-resolution imaging and analysis of skin lesions to improve patient outcomes.
Subscribe To The MoleMax Newsletter
